<DOC>
	<DOCNO>NCT00183040</DOCNO>
	<brief_summary>The purpose study determine relationship deficiencies testosterone growth hormone loss muscle mass ( sarcopenia ) functional impairment age whether interaction two hormone system maintain normal skeletal muscle mass physical function .</brief_summary>
	<brief_title>HORMA : Hormonal Regulators Muscle Metabolism Aging</brief_title>
	<detailed_description>Elderly person experience progressive loss skeletal muscle mass , muscle strength , functional capacity activity daily live . Aging also associate loss hormone believe related muscle strength , namely testosterone growth hormone ( GH ) . The hypothesis test hormone system regulate musculoskeletal protein mass contractile fiber different complimentary mechanism optimal level testosterone GH necessary maintain skeletal muscle mass , muscular strength power , full functional activity daily live age process . This control , 16 week study evaluate independent effect interaction two anabolic hormone system community dwell elderly men 65-90 year age hyposomatotropic ( deficiency growth hormone ) low eugonadal status ( total testosterone 150-550 ng/dL ) . The study utilize two tiered randomization 108 study participant first randomize either low high eugonadal level testosterone use novel Leydig cell clamp method ( GnRH ( gonadotropin-releasing hormone ) agonist plus topical testosterone supplementation ) achieve target level testosterone . Low gonadal status ( 150-550 ng/dL ) maintain 5 g daily dos topical testosterone , whereas high gonadal status ( 650-950 ng/dL ) achieve 10 g daily dos . Within two group , participant randomize receive placebo one two dos rhGH ( recombinant human growth hormone ) therapy ( 0 , 3.0 , 5.0 mcg/kg/day ) double blind fashion .</detailed_description>
	<mesh_term>Sarcopenia</mesh_term>
	<mesh_term>Muscle Weakness</mesh_term>
	<mesh_term>Paresis</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<mesh_term>Testosterone</mesh_term>
	<criteria>Men 6590 year age Total serum IGF1 ( insulinlike growth factor ) low tertile adult ( 56167 ug/dl ) Total serum testosterone 150550 ng/dL BMI ( Body Mass Index ) 35 kg/m2 great Weight instability ( &gt; 3 % change prior 3 month ) Daily intake total kilocalorie less equal 0.8X RDA intake protein 0.8 1.4 g/kg/day inclusive Acute illness prior 30 day Resistance training ( wt lift ) past 12 month Vigorous aerobic sport ( Competing Master athlete prior 5 year ; weekly swimming , racquet ball , cycling , tennis , precede 12 month ) Use anabolic agent ( androgen , androgen precursor , rhGH , etc ) precede 12 month Use medication might affect amino acid metabolism ( e.g . betaadrenergic blocker , betaagonists , Ca2+ channel blocker , corticosteroid ) Fasting sugar great equal 126 mg/dl diabetes require Rx History benign intracranial hypertension Heart failure , active angina , myocardial infarction prior 6 month history aortic stenosis Uncontrolled hypothyroidism hyperthyroidism Rheumatoid arthritis , cirrhosis active hepatitis History carpal tunnel syndrome Prior cancer squamous basal cell carcinoma skin Sleep apnea severe chronic lung disease Anticoagulation heparin coumadin Blood pressure control medication &lt; 180/95 mm Hg Calculated creatinine clearance &lt; 50 cc/min Serum prostatic antigen &gt; 4.0 American Urological Association score great equal 8 Hematocrit great equal 52 % , ALT &gt; 1.5X ULN Failure pas modify Bruce treadmill stress test Severe disability limit strength physical function test Dementia cognitive impairment affect subject 's ability provide inform consent</criteria>
	<gender>Male</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>May 2009</verification_date>
	<keyword>andropause</keyword>
	<keyword>hormone therapy</keyword>
	<keyword>HRT</keyword>
</DOC>